Apyx Medical Corp's fundamentals are relatively healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 115/208 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 5.67.In the medium term, the stock price is expected to trend up.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Apyx Medical Corp's Score
Industry at a Glance
Industry Ranking
115 / 208
Overall Ranking
273 / 4582
Industry
Healthcare Equipment & Supplies
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
4
analysts
Buy
Current Rating
5.667
Target Price
+43.10%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Apyx Medical Corp Highlights
StrengthsRisks
Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.
Growing
The company is in a growing phase, with the latest annual income totaling USD 48.10M.
Undervalued
The company’s latest PE is -9.70, at a low 3-year percentile range.
Apyx Medical Corporation is an advanced energy technology company. The Company's segments include Advanced Energy and Original Equipment Manufacturer (OEM). The Advanced Energy segment's product portfolio consists of Helium Plasma Technology, which is marketed and sold as Renuvion in the cosmetic surgery market, and J-Plasma in the hospital surgical market. It focuses on the cosmetic surgery market, where Renuvion offers plastic surgeons, facial plastic surgeons and cosmetic physicians the ability to provide controlled heat to the tissue to achieve their desired results. These product lines consist of a multifunction generator, a handpiece and a supply of helium gas. Through OEM agreements, the OEM segment produces generators, medical devices, and related accessories for medical device manufacturers as well as start-up businesses in need of its energy-based designs. It specializes in the design, development, and manufacturing of electrosurgical equipment and medical devices.
Ticker SymbolAPYX
CompanyApyx Medical Corp
CEOGoodwin (Charles D)
Websitehttps://apyxmedical.com/
FAQs
What is the current price of Apyx Medical Corp (APYX)?
The current price of Apyx Medical Corp (APYX) is 3.610.
What is the symbol of Apyx Medical Corp?
The ticker symbol of Apyx Medical Corp is APYX.
What is the 52-week high of Apyx Medical Corp?
The 52-week high of Apyx Medical Corp is 4.440.
What is the 52-week low of Apyx Medical Corp?
The 52-week low of Apyx Medical Corp is 0.755.
What is the market capitalization of Apyx Medical Corp?
The market capitalization of Apyx Medical Corp is 136.53M.
What is the net income of Apyx Medical Corp?
The net income of Apyx Medical Corp is -23.46M.
Is Apyx Medical Corp (APYX) currently rated as Buy, Hold, or Sell?
According to analysts, Apyx Medical Corp (APYX) has an overall rating of Buy, with a price target of 5.667.
What is the Earnings Per Share (EPS TTM) of Apyx Medical Corp (APYX)?
The Earnings Per Share (EPS TTM) of Apyx Medical Corp (APYX) is -0.360.